PAGE4 was activated via the stimulation of ROS production, promoting cell survival and reducing cell apoptosis by increasing the phosphorylation of ERK1/2 and decreasing the phosphorylation of JNK1/2, finally leading to the development and progression of BPH. Here, PAGE4 is linked to benign prostatic hyperplasia.